Tsutomu Kawai

Risk stratification of patients with chronic heart failure using cardiac iodine-123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction

Right ventricular (RV) systolic dysfunction has been shown to be an independent predictor of clinical outcome in patients with chronic heart failure (CHF), and cardiac metaiodobenzylguanidine (MIBG) imaging also provides prognostic information. We aimed to evaluate the long‐term predictive value of combining RV systolic dysfunction and abnormal findings of cardiac MIBG imaging on outcome in CHF patients.

NUTRITIONAL ASSESSMENT BY PROGNOSTIC NUTRITIONAL INDEX PROVIDES THE ADDITIONAL LONG-TERM PROGNOSTIC INFORMATION TO BODY MASS INDEX IN PATIENTS ADMITTED WITH ACUTE DECOMPENSATED HEART FAILURE

Obesity Paradox is well recognized in patients (pts) with heart failure. Malnutrition is associated with increased mortality risk in pts with heart failure. However, there is little information available on the long-term prognostic significance of nutritional assessment in patients admitted with

PROGRESSIVE HYPONATREMIA DURING HEART FAILURE TREATMENT PROVIDES ADDITIONAL LONG-TERM PROGNOSTIC INFORMATION TO HEMOCONCENTRATION IN PATIENTS ADMITTED WITH ACUTE DECOMPENSATED HEART FAILURE

Hemoconcentration (HC) during heart failure treatment is known to be associated with decreased mortality and rehospitalization in patients (pts) with acute decompensated heart failure (ADHF). On the other hand, progressive hyponatremia (pro-hypoNa) during hospitalization is reported to be associated

PREDICTION OF MODE OF DEATH IN PATIENTS WITH CHRONIC HEART FAILURE BY CARDIAC I-123 METAIODOBENZYLGUANIDINE IMAGING: A PROSPECTIVE COMPARATIVE STUDY WITH FRAGMENTED QRS COMPLEXES

Background: : Prediction of mode of death (sudden cardiac death (SCD) and pump failure death (PFD)) in patients with chronic heart failure (CHF) may facilitate decisions about specific medications or devices. Cardiac I-123 metaiodobenzylguanidine (MIBG) imaging provides prognostic information in patients with CHF. On the other hand, fragmented QRS complexes (fQRS) on the 12-lead ECG have been associated with poor outcome in CHF patients. However, there is no information available on the comparison of the prognostic value about mode of death between MIBG imaging and fQRS in CHF patients.

MODERATE TO SEVERE ACUTE KIDNEY INJURY DURING HEART FAILURE TREATMENT PROVIDES THE ADDITIONAL LONG-TERM PROGNOSTIC INFORMATION TO MALNUTRITION IN PATIENTS ADMITTED WITH ACUTE DECOMPENSATED HEART FAILURE

Malnutrition is associated with the increased mortality risk in patients (pts) with heart failure. Acute kidney injury (AKI) during heart failure treatment is also associated with poor outcome in pts admitted with acute decompensated heart failure (ADHF). However, there is no information available

EVEN STANDARD DOSE OF FUROSEMIDE IS ASSOCIATED WITH THE PROGRESSION OF CARDIORENAL SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE VIA CARDIAC SYMPATHETIC NERVE ACTIVATION

High dose of loop diuretics has been associated with poor outcome in heart failure patients. However, it remains to be uncertain whether even standard dose of diuretics would be related to worsening renal function and cardiac events in chronic heart failure (CHF) patients, from a viewpoint of

CARDIAC I-123 METAIODOBENZYLGUANIDINE IMAGING COULD IDENTIFY PATIENTS WITH CHRONIC HEART FAILURE AND LVEF<35% AT LOW RISK FOR SUDDEN CARDIAC DEATH FOR FIVE YEARS

Patients (pts) with chronic heart failure (CHF) at risk of sudden cardiac death (SCD) are often treated with implantable cardiac defibrillator (ICD), but current criteria for device use, based largely on LVEF, leads many pts receiving ICDs that never deliver therapy. It is of clinical significance

PERSISTENCE OF HYPONATREMIA IMPLIES LONG-TERM POOR OUTCOMES IN PATIENTS WITH CHRONIC HEART FAILURE

Hyponatremia is a common electrolyte abnormality in patients with chronic heart failure (CHF). It was reported that hyponatremia is associated with increased mortality in CHF patients. However, the prognostic significance of persistent hyponatremia remains to be unclear in CHF patients. We sought to